Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL8450325 | 1.00 | SLC34A1 (0.42) | SLC34A1LMNAMAPT | |
| Phosphoric Acid SCHEMBL28975729 | 1.00 | SLC34A1 (0.42) | SLC34A1LMNAMAPT | |
| Phosphoric Acid SCHEMBL29189684 | 1.00 | SLC34A1 (0.42) | SLC34A1LMNAMAPT | |
| Phosphoric Acid SCHEMBL28408970 | 1.00 | SLC34A1 (0.42) | SLC34A1LMNAMAPT | |
| Phosphoric Acid SCHEMBL11883861 | 1.00 | SLC34A1 (0.42) | SLC34A1LMNAMAPT | |
| Phosphoric Acid SCHEMBL23581849 | 1.00 | SLC34A1 (0.42) | SLC34A1LMNAMAPT | |
| Phosphoric Acid SCHEMBL742814 | 1.00 | SLC34A1 (0.42) | SLC34A1LMNAMAPT | |
| Phosphoric Acid SCHEMBL467211 | 1.00 | SLC34A1 (0.42) | SLC34A1LMNAMAPT | |
| Phosphoric Acid SCHEMBL11565845 | 1.00 | SLC34A1 (0.42) | SLC34A1LMNAMAPT | |
| Phosphoric Acid SCHEMBL210785 | 1.00 | SLC34A1 (0.42) | SLC34A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10209 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250352543-A1 | NANOCRYSTALLINE PREPARATION OF ROCK2 INHIBITOR AND PREPARATION METHOD THEREFOR | BEIJING TIDE PHARMACEUTICAL CO LTD (CN) | 2025-11-20 | — | — | US | claimed |
| EP-3970693-B1 | PHARMACEUTICAL FORMULATIONS COMPRISING CCR3 ANTAGONISTS | ALKAHEST INC (US) | 2025-07-02 | — | — | EP | claimed |
| CN-120022522-A | Drug-loaded microneedle, drug-loaded microneedle patch and electrically-controlled drug release microneedle system | 成都邦迈医创科技有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-119841320-A | Preparation method of porous anode material derived from high-silicon slag | 宜都兴发化工有限公司 | 2025-04-18 | — | — | CN | claimed |
| EP-3965759-B1 | A TABLET FORMULATION COMPRISING LERCANIDIPINE AND ENALAPRIL | SANOVEL ILAC SANAYI VE TICARET AS (TR) | 2025-02-12 | — | — | EP | claimed |
| EP-4434513-A1 | NANOCRYSTALLINE PREPARATION OF ROCK2 INHIBITOR AND PREPARATION METHOD THEREFOR | Beijing Tide Pharmaceutical Co., Ltd. (CN) | 2024-09-25 | — | — | EP | claimed |
| EP-3700574-B1 | FORMULATIONS OF A COMPOUND MODULATING KINASES | PLEXXIKON INC (US) | 2024-08-28 | — | — | EP | claimed |
| US-20240226112-A1 | CERTAIN N-(1-CYANO-2-PHENYLETHYL)-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING CYSTIC FIBROSIS | INSMED INCORPORATED | 2024-07-11 | — | — | US | claimed |
| US-12029820-B2 | Sustained release compositions of 4-aminopyridine | ACORDA THERAPEUTICS, INC. (US) | 2024-07-09 | — | — | US | claimed |
| CN-115105478-B | Lacosamide pharmaceutical composition, preparation method and application thereof | 上海云晟研新生物科技有限公司 | 2024-07-09 | — | — | CN | claimed |
| EP-0396404-A1 | Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine | SCHERING CORPORATION (US) | 1990-11-07 | — | — | EP | claimed |
| US-4795630-A | ABRASIVE, HUMECTANT, BINDER, SURFACTANT AND WATER | LION CORPORATION (JP) | 1989-01-03 | — | — | US | claimed |
| US-4777050-A | IN CELLULOSE POLYMER MATRIX | SCHERING CORPORATION (US) | 1988-10-11 | — | — | US | claimed |
| US-4657757-A | Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate | SCHERING CORPORATION (US) | 1987-04-14 | — | — | US | claimed |
| US-4632824-A | Compositions applied in the mouth | G-C DENTAL INDUSTRIAL CORPORATION (JP) | 1986-12-30 | — | — | US | claimed |
| US-4601894-A | ANALGLE0ICS | SCHERING CORPORATION (US) | 1986-07-22 | — | — | US | claimed |
| EP-0054333-B1 | A PROCESS OF COMPACTING FINE PARTICLES OF CALCIUM PHOSPHATE AND THE COMPACTS OBTAINED THEREBY | STAUFFER CHEMICAL COMPANY (US) | 1986-04-09 | — | — | EP | claimed |
| US-4122151-A | Process of stabilization of dibasic calcium phosphate dihydrate against hydrolysis with cyclic aminophosphonic acids | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1978-10-24 | — | — | US | claimed |
| US-4117090-A | TOOTHPASTES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1978-09-26 | — | — | US | claimed |
| US-4117086-A | TOOTHPASTES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1978-09-26 | — | — | US | claimed |